PMC10368101_01
Oral MF in patient 1.
cde-2023-0015-0001-530935_F01.jpg
PMC10368101_01_cde-2023-0015-0001-530935_F01.jpg
F1
Six months after completing the second round of TSEBT (30 Gy), he had cutaneous progression and developed a lesion on his hard palate (as shown in Fig. 1) that was biopsy proven to be a T-cell lymphoma consistent with his MF.
PMC10368101_02
MF lesions on the tongue of patient 2.
cde-2023-0015-0001-530935_F02.jpg
PMC10368101_02_cde-2023-0015-0001-530935_F02.jpg
F2
Response lasted 4 months when the patient started to develop new lesions on the tongue outside of the radiation field (shown in Fig. 2).